| Bioactivity | 2-β-D-Ribofuranosyl-2H-pyrazolo[3,4-d]pyrimidine-4,6-diamine is a purine nucleoside analogue. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1]. |
| Name | 2-β-D-Ribofuranosyl-2H-pyrazolo[3,4-d]pyrimidine-4,6-diamine |
| CAS | 124137-35-5 |
| Formula | C10H14N6O4 |
| Molar Mass | 282.26 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Robak T, Robak P. Purine nucleoside analogs in the treatment of rarer chronic lymphoid leukemias. Curr Pharm Des. 2012;18(23):3373-88. |
2-β-D-Ribofuranosyl-2H-pyrazolo[3,4-d]pyrimidine-4,6-diamine
CAS: 124137-35-5 F: C10H14N6O4 W: 282.26
2-β-D-Ribofuranosyl-2H-pyrazolopyrimidine-4,6-diamine is a purine nucleoside analogue. Purine nucleoside analogs have b
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.